Proteomic Characterization of Plasma in Lemierre's Syndrome
Thrombosis and Haemostasis · 01.05.2024 · 124 (05) · 432-440
DOI: 10.1055/a-2195-3927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.05.2024. Verfasst von David Nygren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Lemierre Syndrome, Proteomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Royal Physiographic Society in Lund.
Abstract (Originalsprache)
Background
The underlying mechanisms of thrombosis in Lemierre's syndrome and other septic thrombophlebitis are incompletely understood. Therefore, in this case control study we aimed to generate hypotheses on its pathogenesis by studying the plasma proteome in patients with these conditions.
Methods
All patients with Lemierre's syndrome in the Skåne Region, Sweden, were enrolled prospectively during 2017 to 2021 as cases. Age-matched patients with other severe infections were enrolled as controls. Patient plasma samples were analyzed using label-free data-independent acquisition liquid chromatography tandem mass spectrometry. Differentially expressed proteins in Lemierre's syndrome versus other severe infections were highlighted. Functions of differentially expressed proteins were defined based on a literature search focused on previous associations with thrombosis.
Results
Eight patients with Lemierre's syndrome and 15 with other severe infections were compared. Here, 20/449 identified proteins were differentially expressed between the groups. Of these, 14/20 had functions previously associated with thrombosis. Twelve of 14 had a suggested prothrombotic effect in Lemierre's syndrome, whereas 2/14 had a suggested antithrombotic effect.
Conclusion
Proteins involved in several thrombogenic pathways were differentially expressed in Lemierre's syndrome compared to other severe infections. Among identified proteins, several were associated with endothelial damage, platelet activation, and degranulation, and warrant further targeted studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infection Medicine, Lund University, Lund, Sweden.
- Department of Infectious Diseases, Skåne University Hospital, Lund/Malmö, Sweden.
- Department of Translational Medicine, Clinical Infection Medicine, Lund University, Malmö, Sweden.
- Center of Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden.
- The Swedish National Infrastructure for Biological Mass Spectrometry (BioMS), Lund University, Lund, Sweden.
Förderung
- The Royal Physiographic Society in Lund
Zitieren
APA
Nygren, D., Torisson, G., Happonen, L., Mellhammar, L., Linder, A., Elf, J., Yan, H., Welinder, C., & Holm, K. (2024). Proteomic Characterization of Plasma in Lemierre's Syndrome. Thrombosis and Haemostasis, 124(05), 432-440. https://doi.org/10.1055/a-2195-3927
Vancouver
Nygren D, Torisson G, Happonen L, Mellhammar L, Linder A, Elf J, et al. Proteomic Characterization of Plasma in Lemierre's Syndrome. Thrombosis and Haemostasis. 2024;124(05):432-440. doi:10.1055/a-2195-3927
BibTeX
@article{Nygren2024,
author = {Nygren, David and Torisson, Gustav and Happonen, Lotta and Mellhammar, Lisa and Linder, Adam and Elf, Johan and Yan, Hong and Welinder, Charlotte and Holm, Karin},
title = {Proteomic Characterization of Plasma in Lemierre's Syndrome},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {05},
pages = {432--440},
doi = {10.1055/a-2195-3927}
}
EUVIMED